Therapeutics: MicroRNA-3662 (miR-3662)

Cancer

INDICATION: Acute myelogenous leukemia (AML)

Cell culture and mouse studies suggest miR-3662 could

Read the full 124 word article

How to gain access

Continue reading with a
two-week free trial.